Clinical Outcomes in COVID-19 Patients Treated with Immunotherapy

SIMPLE SUMMARY: Patients with cancer who contract COVID-19 are very vulnerable to increased complications and illness while actively being treated with chemotherapy or immune checkpoint inhibitors (ICIs). The aim of this retrospective review was to describe the disease course and identify specific r...

Descripción completa

Detalles Bibliográficos
Autores principales: Hatic, Haris, Hearld, Kristine R., Das, Devika, Deshane, Jessy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9735726/
https://www.ncbi.nlm.nih.gov/pubmed/36497435
http://dx.doi.org/10.3390/cancers14235954

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9735726/
https://www.ncbi.nlm.nih.gov/pubmed/36497435
http://dx.doi.org/10.3390/cancers14235954

Ejemplares similares